VOR
Vor Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.05
+3.34%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.81
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$1.16
- EPS estimate
- -$0.69
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -19.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026